Biomedical Engineering Reference
In-Depth Information
[37] Chanyaputhipong J, Low s-CA, Chow pK. Gadoxetate acid-enhanced MR imaging for
HCC: a review for clinicians. Int J Hepatol 2011;
2011
:489342.
[38] Klessen C, Hein pA, Huppertz A, Voth M, Wagner M, elgeti T, Kroll H, Hamm B,
Taupitz M, Asbach p. First-pass whole-body magnetic resonance angiography (MRA)
using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopen-
tetate dimeglumine. Invest Radiol 2007;
42
:659-664.
[39] spanoghe M, Lanens d, dommisse R, Van der Linden A, Alderweireldt F. proton relaxa-
tion enhancement by means of serum albumin and poly-l-lysine labeled with dTpA-Gd3+:
Relaxivities as a function of molecular weight and conjugation efficiency. Magn Reson
Imaging 1992;
10
:913-917.
[40] sieving pF, Watson Ad, Rocklage sM. preparation and characterization of paramagnetic
polychelates and their protein conjugates. Bioconjug Chem 1990;
1
:65-71.
[41] schuhmann-Giampieri G, schmitt-Willich H, Frenzel T, press W-R, Weinmann H-J.
In vivo
and in vitro evaluation of Gd-dTpA-polylysine as a macromolecular contrast
agent for magnetic resonance imaging. Invest Radiol 1991;
26
:969-974.
[42] Van Hecke p, Marchal G, Bosmans H, Johannik K, Jiang Y, Vogler H, Van Ongeval C,
Baert A, speck u. nMR imaging study of the pharmacodynamics of polylysine-gadolin-
ium-dTpA in the rabbit and the rat. Magn Reson Imaging 1991;
9
:313-321.
[43] Vexler Vs, Clément O, schmitt-Willich H, Brasch RC. effect of varying the molecular
weight of the MR contrast agent Gd-dTpA-polylysine on blood pharmacokinetics and
enhancement patterns. J Magn Reson Imaging 1994;
4
:381-388.
[44] Marchal G, Bosmans H, Van Hecke p, speck u, Aerts p, Vanhoenacker p, Baert AL.
MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits.
Am J Roentgenol 1990;
155
:407-411.
[45] Berthezene Y, Vexler V, Jerome H, sievers R, Moseley Me, Brasch RC. differentiation
of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging
contrast agent. Radiology 1991;
181
:773-777.
[46] Berthezène Y, Vexler V, price dC, Wisner-dupon J, Moseley Me, Aicher Kp, Brasch RC.
Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit
using a macromolecular contrast agent: polylysine-gadolinium-dTpA40. Invest Radiol
1992;
27
:346-351.
[47] Berthezène Y, Vexler V, Kuwatsuru R, Rosenau W, Mühler A, Clément O, price dC,
Brasch RC. differentiation of alveolitis and pulmonary fibrosis with a macromolecular
MR imaging contrast agent. Radiology 1992;
185
:97-103.
[48] Opsahl LR, uzgiris ee, Vera dR. Tumor imaging with a macromolecular paramagnetic
contrast agent: gadopentetate dimeglumine-polylysine. Acad Radiol 1995;
2
:762-766.
[49] desser Ts, Rubin dL, Muller HH, Qing F, Khodor s, Zanazzi G, Young sW, Ladd dL,
Wellons JA, Kellar Ke. dynamics of tumor imaging with Gd-dTpA—polyethylene glycol
polymers: dependence on molecular weight. J Magn Reson Imaging 1994;
4
:467-472.
[50] Bogdanov AA, Weissleder R, Frank HW, Bogdanova AV, nossif n, schaffer BK, Tsai e,
papisov MI, Brady TJ. A new macromolecule as a contrast agent for MR angiography:
preparation, properties, and animal studies. Radiology 1993;
187
:701-706.
[51] Cavagna F, Luchinat C, scozzafava A, Xia Z. polymetallic macromolecules are potential
contrast agents of improved efficiency. Magn Reson Med 1994;
31
:58-60.
[52] Lucas RL, Benjamin M, Reineke TM. Comparison of a tartaric acid derived polymeric
MRI contrast agent to a small molecule model chelate. Bioconjug Chem 2007;
19
:24-27.
Search WWH ::
Custom Search